A detailed history of Geode Capital Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 768,740 shares of KOD stock, worth $6.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
768,740
Previous 755,957 1.69%
Holding current value
$6.73 Million
Previous $1.78 Million 12.95%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.2 - $3.25 $28,122 - $41,544
12,783 Added 1.69%
768,740 $2.01 Million
Q2 2024

Aug 09, 2024

BUY
$2.29 - $4.48 $75,560 - $147,822
32,996 Added 4.56%
755,957 $1.78 Million
Q1 2024

May 13, 2024

BUY
$3.01 - $7.45 $44,295 - $109,634
14,716 Added 2.08%
722,961 $3.8 Million
Q4 2023

Feb 13, 2024

BUY
$1.4 - $3.24 $50,401 - $116,643
36,001 Added 5.36%
708,245 $2.15 Million
Q3 2023

Nov 13, 2023

BUY
$1.8 - $7.49 $4,847 - $20,170
2,693 Added 0.4%
672,244 $1.21 Million
Q2 2023

Aug 11, 2023

BUY
$4.3 - $9.48 $185,618 - $409,223
43,167 Added 6.89%
669,551 $4.62 Million
Q1 2023

May 15, 2023

BUY
$4.81 - $8.88 $73,386 - $135,482
15,257 Added 2.5%
626,384 $3.88 Million
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $171,280 - $211,473
26,270 Added 4.49%
611,127 $4.38 Million
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $161,990 - $267,487
-21,399 Reduced 3.53%
584,857 $4.53 Million
Q2 2022

Aug 12, 2022

BUY
$5.04 - $9.48 $432,920 - $814,303
85,897 Added 16.51%
606,256 $4.63 Million
Q1 2022

May 13, 2022

SELL
$7.09 - $89.45 $569,695 - $7.19 Million
-80,352 Reduced 13.38%
520,359 $4.02 Million
Q4 2021

Feb 11, 2022

BUY
$80.85 - $128.49 $1.14 Million - $1.81 Million
14,121 Added 2.41%
600,711 $50.9 Million
Q3 2021

Nov 12, 2021

BUY
$81.97 - $106.94 $846,504 - $1.1 Million
10,327 Added 1.79%
586,590 $56.3 Million
Q2 2021

Aug 13, 2021

BUY
$77.2 - $126.54 $1.57 Million - $2.57 Million
20,304 Added 3.65%
576,263 $53.6 Million
Q1 2021

May 12, 2021

BUY
$110.45 - $164.47 $4.31 Million - $6.42 Million
39,016 Added 7.55%
555,959 $63 Million
Q4 2020

Feb 12, 2021

BUY
$60.78 - $154.03 $5.83 Million - $14.8 Million
95,925 Added 22.78%
516,943 $75.9 Million
Q3 2020

Nov 13, 2020

BUY
$45.05 - $59.27 $31,174 - $41,014
692 Added 0.16%
421,018 $24.9 Million
Q2 2020

Aug 13, 2020

BUY
$42.74 - $66.25 $609,728 - $945,122
14,266 Added 3.51%
420,326 $22.7 Million
Q1 2020

May 14, 2020

BUY
$38.18 - $73.95 $3.02 Million - $5.84 Million
79,024 Added 24.16%
406,060 $19.4 Million
Q4 2019

Feb 13, 2020

BUY
$13.9 - $76.65 $1.02 Million - $5.63 Million
73,409 Added 28.94%
327,036 $23.5 Million
Q3 2019

Nov 12, 2019

BUY
$10.24 - $17.57 $705,116 - $1.21 Million
68,859 Added 37.27%
253,627 $3.65 Million
Q2 2019

Aug 14, 2019

BUY
$6.2 - $12.0 $671,850 - $1.3 Million
108,363 Added 141.83%
184,768 $2.16 Million
Q1 2019

May 14, 2019

BUY
$6.43 - $9.44 $76,156 - $111,807
11,844 Added 18.35%
76,405 $498,000
Q4 2018

Feb 13, 2019

BUY
$6.11 - $10.43 $394,467 - $673,371
64,561 New
64,561 $458,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.